Skip to main content
Screener/Healthcare/Biotechnology

VRDN — Viridian Therapeutics, Inc.

NASDAQ
$24.46-0.34 (-1.35%)
Mid CapUnder $50HealthcareFastest Growing
$13.18
$34.29
$24.14
$25.00
EPS (TTM)$-3.48
P/E Ratio-3.37
Dividend Yield—
Market Cap$2.53B
Volume1.14M
Prev Close$24.80
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$141K-$104.9M$-1.0314.2%-74397.9%
Q4 '25$132K-$120.4M$-1.11-142.4%-91178.0%
Q3 '25$70.6M-$34.6M$-0.34100.0%-49.0%
Q2 '25$75K-$100.7M$-1.00100.0%-134313.3%
Q1 '25$72K-$86.9M$-0.87100.0%-120711.1%
Q4 '24$72K-$79.7M$-0.81100.0%-110729.2%
Q3 '24$86K-$76.7M$-1.15100.0%-89173.3%
Q2 '24$72K-$65.0M$-1.02100.0%-90268.1%
Get Your Daily Market Recap